Korean Journal of Gynecologic Oncology  2007;18(2):160-164

Malignant lymphoma of the uterine cervix treated by neoadjuvant chemotherapy.

Soon Ho HWANG 1 ; Bo Yeon KIM ; Jin Hee PARK ; Kyung Eun LEE ; Min A LEE ; Ki Hwan LEE ; Heung Tae NOH ; Sung Kyong SON

Affiliations

+expand

Keywords

Lymphoma; Cervical lymphoma; Neoadjuvant chemotherapy

Country

Republic of Korea

Language

Korean

Abstract

Non-Hodgkin's lymphoma presented as a malignancy of the uterine cervix is exceedingly rare disease and accounts for approximately only 0.12-0.6% of extranodal lymphomas. There is no consensus on the management and prognosis of the disease because of its extreme rarity. Previously, treatment of this disease has been radiation therapy, surgery or chemotherapy either alone or in combination. We present the case of a 45-year-old woman diagnosed with diffuse, large B-cell non-Hodgkin's lymphoma of the uterine cervix. We administered neoadjuvant chemotherapy according to CHOP protocol (cyclophosphamide, adriamycin, vincristine, and prednisone) followed by hysterectomy and bilateral salpingo-oophorectomy. The patient is alive 20 months after the initial diagnosis. We report the case with a brief review of literature.